Concepedia

Publication | Open Access

Post‐marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab

DOIFull Paper Access

28

Citations

18

References

2008

Year

Víctor M. González, Esther Salgueiro, Francisco J. Jimeno, Agustı́n Hidalgo, Teresa Rubio, Gloria Manso
Pharmacoepidemiology and Drug Safety

Abstract

Our results are consistent with the safety profile of rituximab and trastuzumab observed in large randomised clinical trials.

References

YearCitations

Page 1